Senior insider sale
EVP & GENERAL COUNSEL at UNITED THERAPEUTICS CORP — senior position signals high conviction
$35.16M
74.30K shares
What this filing means
MAHON PAUL A plans to sell 74.30K shares of UNITED THERAPEUTICS CORP valued at approximately $35.16M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/2/2026ACC: 0001950047-26-000026
Officer· EVP & GENERAL COUNSEL
Since Mar 2026
74.30K
Shares to sell
$35.16M
Approx. market value
8.30K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
1/2/2026
8.30KTotal acquired8.30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2026 | Stock Option Exercise Cash | 8.30K | — |
| Total | 8.30K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
11K
Market value
$5.64M
12/24/2025
—Completed
Units to sell
11K
Market value
$5.33M
12/11/2025
—Completed
Units to sell
11K
Market value
$5.35M
11/26/2025
—Completed
Units to sell
11K
Market value
$5.11M
11/13/2025
—Completed
Units to sell
11K
Market value
$4.95M
10/30/2025
—Completed
Units to sell
11K
Market value
$4.75M
10/16/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.30K
Market value
$4.03M
1/2/2026
Total
Units
74.30K
Value
$35.16M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/24/2025 | 11K | $5.64M | — | Completed |
12/11/2025 | 11K | $5.33M | — | Completed |
11/26/2025 | 11K | $5.35M | — | Completed |
11/13/2025 | 11K | $5.11M | — | Completed |
10/30/2025 | 11K | $4.95M | — | Completed |
10/16/2025 | 11K | $4.75M | — | Completed |
| Planned — Approximate Date | ||||
1/2/2026 | 8.30K | $4.03M | NASDAQ | Planned |
| Total | 74.30K | $35.16M | ||